What is the impact of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma?

Mototsugu Oya, Masaru Murai

Research output: Contribution to journalArticle

Abstract

The impact of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma (RCC) is discussed herein with consideration of prolonged survival and quality of life. A nephrectomy can be indicated in a patient with good performance status and pulmonary metastases when adjuvant immunotherapy is an option. In contrast, in a patient with poor performance status and/or metastases including multiple organs, a nephrectomy is not indicated. To relieve symptoms, options other than nephrectomy should be considered.

Original languageEnglish
Pages (from-to)1732-1737
Number of pages6
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume29
Issue number10
Publication statusPublished - 2002 Oct

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'What is the impact of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma?'. Together they form a unique fingerprint.

  • Cite this